Logo for Gabather

Gabather Investor Relations Material

Latest events

Logo for Gabather

Investor Update

Gabather
Logo for Gabather

Investor Update

11 Mar, 2025
Logo for Gabather

Investor Update

6 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Gabather

Access all reports
Gabather AB is a pharmaceutical company dedicated to developing therapeutics for central nervous system diseases. The company focuses on creating novel drug candidates primarily for the treatment of neuropsychiatric disorders, including anti-psychotics, anti-depressants, anxiolytics, analgesics, and cognition-enhancing treatments. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.